Cargando…
Pembrolizumab输注过程中出现低血压：病例报告并文献综述
Immunological checkpoint inhibitors have been approved for a short period of time in China, and real-world clinical data are still in the collection stage. Reports of domestic programmed death-1 (PD-1) treatment-related adverse reactions are rare. The author reported a case of hypotension in the pro...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885412/ https://www.ncbi.nlm.nih.gov/pubmed/31771745 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.11.09 |